Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 329

Similar articles for PubMed (Select 23242718)

1.
2.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
3.

Molecular imaging: current status and emerging strategies.

Pysz MA, Gambhir SS, Willmann JK.

Clin Radiol. 2010 Jul;65(7):500-16. doi: 10.1016/j.crad.2010.03.011. Review.

4.

Current advances in molecular imaging of gene and cell therapy for cancer.

Shah K.

Cancer Biol Ther. 2005 May;4(5):518-23. Epub 2005 May 5. Review.

PMID:
15908803
5.

A realistic utilization of nanotechnology in molecular imaging and targeted radiotherapy of solid tumors.

Patel V, Papineni RV, Gupta S, Stoyanova R, Ahmed MM.

Radiat Res. 2012 Apr;177(4):483-95. Epub 2012 Mar 9. Review.

PMID:
22404738
6.

Molecular imaging in the framework of personalized cancer medicine.

Belkić D, Belkić K.

Isr Med Assoc J. 2013 Nov;15(11):665-72.

7.

Molecular imaging-guided theranostics and personalized medicine.

Zhang H, Tian M, Li E, Fujibayashi Y, Shen LH, Yang DJ.

J Biomed Biotechnol. 2012;2012:747416. doi: 10.1155/2012/747416. Epub 2012 Jul 18. No abstract available.

8.

Oncologic imaging end-points for the assessment of therapy response.

Serkova NJ, Garg K, Bradshaw-Pierce EL.

Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):36-53. Review.

PMID:
19149687
9.

Tumor blood vessel visualization.

Missbach-Guentner J, Hunia J, Alves F.

Int J Dev Biol. 2011;55(4-5):535-46. doi: 10.1387/ijdb.103229jm. Review.

10.

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, Ameer-Beg SM, Vojnovic B, Gillett C, Coolen A, Kéri G, Ellis PA, Ng T.

Target Oncol. 2009 Sep;4(3):235-52. doi: 10.1007/s11523-009-0116-y. Epub 2009 Sep 16. Review.

11.

Theranostics: combining imaging and therapy.

Kelkar SS, Reineke TM.

Bioconjug Chem. 2011 Oct 19;22(10):1879-903. doi: 10.1021/bc200151q. Epub 2011 Aug 29. Review.

PMID:
21830812
12.

New strategy for monitoring targeted therapy: molecular imaging.

Teng FF, Meng X, Sun XD, Yu JM.

Int J Nanomedicine. 2013;8:3703-13. doi: 10.2147/IJN.S51264. Epub 2013 Sep 30. Review.

13.

A review of NIR dyes in cancer targeting and imaging.

Luo S, Zhang E, Su Y, Cheng T, Shi C.

Biomaterials. 2011 Oct;32(29):7127-38. doi: 10.1016/j.biomaterials.2011.06.024. Epub 2011 Jul 2. Review.

PMID:
21724249
14.

Molecular-genetic imaging based on reporter gene expression.

Kang JH, Chung JK.

J Nucl Med. 2008 Jun;49 Suppl 2:164S-79S. doi: 10.2967/jnumed.107.045955. Review.

15.

Tumor models and specific contrast agents for small animal imaging in oncology.

Ni Y, Wang H, Chen F, Li J, DeKeyzer F, Feng Y, Yu J, Bosmans H, Marchal G.

Methods. 2009 Jun;48(2):125-38. doi: 10.1016/j.ymeth.2009.03.014. Epub 2009 Mar 26.

PMID:
19328231
16.

Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.

Schmidt GP, Kramer H, Reiser MF, Glaser C.

Top Magn Reson Imaging. 2007 Jun;18(3):193-202. Review.

PMID:
17762383
17.

[Current state of molecular imaging research].

Grimm J, Wunder A.

Rofo. 2005 Mar;177(3):326-37. Review. German.

PMID:
15719293
18.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
19.

PET in oncology: will it replace the other modalities?

Hoh CK, Schiepers C, Seltzer MA, Gambhir SS, Silverman DH, Czernin J, Maddahi J, Phelps ME.

Semin Nucl Med. 1997 Apr;27(2):94-106. Review.

PMID:
9144854
20.

Molecular imaging perspectives.

Cassidy PJ, Radda GK.

J R Soc Interface. 2005 Jun 22;2(3):133-44. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk